Sotera Health (SHC): are the analysts right?

Sotera Health · Health Care · ref. ETF XLV · 50 calls · price $17.39
What the company does: Sotera Health Company fournit solutions de stérilisation, tests de laboratoire et services consultatifs pour l'industrie de la santé en Amérique du Nord et Europe.
📈 1-year price
$18.02+55.5% over range
Jul 8, 25low $11.01 · high $19.35Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 4 analysts

🎯 Analyst price target on SHC

High target · 1 analyst$23+32.3%
Median target · 4 analysts$21+20.8%
Low target · 1 analyst$19+9.3%
Current price$17.39

🗳️ The analyst consensus

Analyst breakdown · 4 (6 months)
Strong Buy0%
Buy100%
Hold0%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on SHC

Most reliable analysts on SHC (% profitable · 365j · ≥2 calls)
Barclays 36% -11.0% 14
RBC Capital 33% +5.9% 9
Citigroup 0% -5.1% 2
Keybanc 0% -27.7% 2

📊 What $1,000 invested in Sotera Health would be worth

In short — $1,000 invested in Sotera Health 10 years ago would be worth $707 today, i.e. -6%/yr on average. Best year: 2023 (+102%), worst: 2022 (-65%). Price performance, excluding dividends.

If I'd invested $1,000 in Sotera Health

InvestmentWorth todayGain
1 years ago$1,302+30%
3 years ago$2,131+113%
5 years ago$647-35%
since inception (2020)$707-29%

Return by year (Sotera Health)

YearReturn$1,000 invested at year start
2026 (YTD)+0%$1,003 (+0%)
2025+30%$1,302 (+30%)
2024-19%$1,053 (+5%)
2023+102%$2,131 (+113%)
2022-65%$754 (-25%)
2021-14%$647 (-35%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on SHC

Barclays
Jun 24, 26
▲ Overweight · 🎯$19
Price at call : $17.1 — upside +11%
Today : $17.39 — upside +9%
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Jun 24, 27
▲ Buy · 🎯$20
Price at call : $15.62 — upside +28%
Today : $17.39 — upside +15%
🎯 on SHC : 100% (1 call matured) · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Jun 5, 27
▲ Overweight · 🎯$22
Price at call : $15.67 — upside +40%
Today : $17.39 — upside +27%
🎯 on SHC : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : May 6, 27
Barclays
Apr 14, 26
▲ Overweight · 🎯$18
Price at call : $16.03 — upside +12%
Today : $17.39 — upside +4%
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Apr 14, 27
Citigroup
Feb 24, 26
▲ Buy · 🎯$23
Price at call : $16.16 — upside +42%
Today : $17.39 — upside +32%
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Feb 24, 27
▲ Overweight · 🎯$24
Price at call : $19.2 — upside +25%
Today : $17.39 — upside +38%
🎯 on SHC : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Jan 9, 27
William Blair
Dec 18, 25
▲ Outperform
🎯 on SHC : no call matured yet · 📊 on Health : 47.4% · +30.6% (19 calls)
in progress (365j)
matures : Dec 18, 26
BMO Capital
Nov 13, 25
▲ Outperform · 🎯$19
Price at call : $16.01 — upside +19%
Today : $17.39 — upside +9%
🎯 on SHC : no call matured yet · 📊 on Health : 41.9% · +5.4% (31 calls)
in progress (365j)
matures : Nov 13, 26
JP Morgan
Nov 5, 25
■ Neutral neutral · not a buy · 🎯$16
Price at call : $16.01 — gap to target -0%
Today : $17.39 — gap to target -8%
🎯 on SHC : 0% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Nov 5, 26
Barclays
Nov 5, 25
▲ Overweight · 🎯$20
Price at call : $16.01 — upside +25%
Today : $17.39 — upside +15%
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Nov 5, 26
■ Neutral neutral · not a buy · 🎯$17
Price at call : $16.01 — gap to target +6%
Today : $17.39 — gap to target -2%
🎯 on SHC : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Nov 5, 26
Barclays
Oct 2, 25
▲ Overweight · 🎯$19
Price at call : $15.88 — upside +20%
Today : $17.39 — upside +9%
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 2, 26
Barclays
Jun 24, 25
▲ Overweight · 🎯$13
Price at call : $11.14 — upside +17%
Today : $17.39 — upside -25%
Expected +17% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+53.5%
stock +54% · XLV +16%
▲ Buy · 🎯$17
Price at call : $12.92 — upside +32%
Today : $17.39 — upside -2%
Expected +32% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 100% (1 call matured) · 📊 on Health : 52.2% · +7.8% (90 calls)
+18.6%
stock +19% · XLV +5%
Piper Sandler
Apr 23, 25
■ Neutral neutral · not a buy · 🎯$13
Price at call : $11.3 — gap to target +15%
Today : $17.39 — gap to target -25%
🎯 on SHC : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Apr 23, 26
Barclays
Apr 10, 25
▲ Overweight · 🎯$12
Price at call : $10.51 — upside +14%
Today : $17.39 — upside -31%
Expected +14% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+49.4%
stock +49% · XLV +8%
Barclays
Feb 28, 25
▲ Overweight · 🎯$16
Price at call : $11.68 — upside +37%
Today : $17.39 — upside -8%
Expected +37% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+36.2%
stock +36% · XLV +6%
Barclays
Feb 18, 25
▲ Overweight · 🎯$17
Price at call : $13.5 — upside +26%
Today : $17.39 — upside -2%
Expected +26% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+29.3%
stock +29% · XLV +9%
RBC Capital
Nov 21, 24
▲ Outperform · 🎯$17
Price at call : $12.82 — upside +33%
Today : $17.39 — upside -2%
Expected +33% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+30.9%
stock +31% · XLV +8%
Citigroup
Nov 6, 24
▲ Buy · 🎯$20
Price at call : $15.83 — upside +26%
Today : $17.39 — upside +15%
Expected +26% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 56.8% · +16.5% (118 calls)
-0.9%
stock -1% · XLV -2%
Barclays
Aug 6, 24
▲ Overweight · 🎯$17
Price at call : $14.39 — upside +18%
Today : $17.39 — upside -2%
Expected +18% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-22.0%
stock -22% · XLV -12%
RBC Capital
Aug 6, 24
▲ Outperform · 🎯$17
Price at call : $14.7 — upside +16%
Today : $17.39 — upside -2%
Expected +16% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-24.8%
stock -25% · XLV -12%
Piper Sandler
May 21, 24
■ Neutral neutral · not a buy · 🎯$13
Price at call : $10.89 — gap to target +19%
Today : $17.39 — gap to target -25%
🎯 on SHC : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : May 21, 25
Barclays
Apr 10, 24
▲ Overweight · 🎯$14
Price at call : $11.42 — upside +23%
Today : $17.39 — upside -19%
Expected +23% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-8.0%
stock -8% · XLV -3%
Citigroup
Apr 3, 24
▲ Buy · 🎯$16
Price at call : $11.4 — upside +40%
Today : $17.39 — upside -8%
Expected +40% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 56.8% · +16.5% (118 calls)
-9.3%
stock -9% · XLV -5%
Jefferies
Mar 25, 24
▲ Buy · 🎯$15.5
Price at call : $11.75 — upside +32%
Today : $17.39 — upside -11%
Expected +32% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 100% (1 call matured) · 📊 on Health : 48% · +9.7% (98 calls)
+1.5%
stock +2% · XLV +0%
RBC Capital
Mar 11, 24
▲ Outperform · 🎯$20
Price at call : $13.77 — upside +45%
Today : $17.39 — upside +15%
Expected +45% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-18.1%
stock -18% · XLV -2%
RBC Capital
Mar 4, 24
▲ Outperform · 🎯$20
Price at call : $14 — upside +43%
Today : $17.39 — upside +15%
Expected +43% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-15.6%
stock -16% · XLV +3%
Barclays
Feb 28, 24
▲ Overweight · 🎯$19
Price at call : $15.01 — upside +27%
Today : $17.39 — upside +9%
Expected +27% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-16.9%
stock -17% · XLV +3%
Keybanc
Feb 6, 24
■ Sector Weight neutral · not a buy
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 33.3% · -8.8% (42 calls)
in progress (365j)
matures : Feb 5, 25
Barclays
Jan 25, 24
▲ Overweight · 🎯$17
Price at call : $14.98 — upside +13%
Today : $17.39 — upside -2%
Expected +13% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-6.9%
stock -7% · XLV +6%
RBC Capital
Nov 2, 23
▲ Outperform · 🎯$20
Price at call : $13.21 — upside +51%
Today : $17.39 — upside +15%
Expected +51% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+19.6%
stock +20% · XLV +15%
Barclays
Nov 2, 23
▲ Overweight · 🎯$15
Price at call : $13.21 — upside +14%
Today : $17.39 — upside -14%
Expected +14% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+19.6%
stock +20% · XLV +15%
RBC Capital
Aug 4, 23
▲ Outperform · 🎯$22
Price at call : $16.89 — upside +30%
Today : $17.39 — upside +27%
Expected +30% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-15.8%
stock -16% · XLV +10%
Keybanc
Aug 4, 23
▲ Overweight · 🎯$23
Price at call : $17.8 — upside +29%
Today : $17.39 — upside +32%
Expected +29% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 33.3% · -8.8% (42 calls)
-20.1%
stock -20% · XLV +11%
Keybanc
Jun 26, 23
▲ Overweight · 🎯$24
Price at call : $18.42 — upside +30%
Today : $17.39 — upside +38%
Expected +30% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 33.3% · -8.8% (42 calls)
-35.2%
stock -35% · XLV +12%
Keybanc
Jun 22, 23
■ Sector Weight neutral · not a buy
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 33.3% · -8.8% (42 calls)
in progress (365j)
matures : Jun 21, 24
RBC Capital
May 4, 23
▲ Outperform · 🎯$18
Price at call : $15.02 — upside +20%
Today : $17.39 — upside +4%
Expected +20% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-24.8%
stock -25% · XLV +6%
Barclays
May 4, 23
▲ Overweight · 🎯$20
Price at call : $15.05 — upside +33%
Today : $17.39 — upside +15%
Expected +33% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-26.8%
stock -27% · XLV +6%
Barclays
Apr 4, 23
▲ Overweight · 🎯$21
Price at call : $17.1 — upside +23%
Today : $17.39 — upside +21%
Expected +23% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-32.5%
stock -33% · XLV +10%
RBC Capital
Mar 1, 23
▲ Outperform · 🎯$19
Price at call : $17.08 — upside +11%
Today : $17.39 — upside +9%
Expected +11% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-12.1%
stock -12% · XLV +14%
JP Morgan
Jan 23, 23
■ Neutral neutral · not a buy · 🎯$18
Price at call : $17.3 — gap to target +4%
Today : $17.39 — gap to target +4%
🎯 on SHC : 0% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Jan 23, 24
Barclays
Jan 11, 23
▲ Overweight · 🎯$22
Price at call : $17.64 — upside +25%
Today : $17.39 — upside +27%
Expected +25% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-13.5%
stock -13% · XLV +4%
▲ Outperform · 🎯$25
Price at call : $17.64 — upside +42%
Today : $17.39 — upside +44%
Expected +42% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (1 call matured) · 📊 on Health : 46.2% · +2.9% (13 calls)
-13.5%
stock -13% · XLV +4%
Goldman Sachs
Nov 23, 22
■ Neutral neutral · not a buy · 🎯$8
Price at call : $8.15 — gap to target -2%
Today : $17.39 — gap to target -54%
🎯 on SHC : 100% (1 call matured) · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Nov 23, 23
Barclays
Nov 16, 22
▼ Underweight · 🎯$6
Price at call : $6.28 — upside -4%
Today : $17.39 — upside -65%
Expected -4% · Actual +119% · Reason (≤ −15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-118.8%
stock +119% · XLV -3%
Barclays
Nov 15, 22
▼ Underweight · 🎯$6
Price at call : $6.97 — upside -14%
Today : $17.39 — upside -65%
Expected -14% · Actual +97% · Reason (≤ −15%) : ✗ No
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-97.3%
stock +97% · XLV -4%
JP Morgan
Nov 3, 22
▼ Underweight · 🎯$6
Price at call : $6.26 — upside -4%
Today : $17.39 — upside -65%
Expected -4% · Actual +114% · Reason (≤ −15%) : ✗ No
🎯 on SHC : 0% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
-113.9%
stock +114% · XLV -2%
RBC Capital
Nov 3, 22
▲ Outperform · 🎯$8
Price at call : $6.26 — upside +28%
Today : $17.39 — upside -54%
Expected +28% · Actual +114% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 33% (9 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+113.9%
stock +114% · XLV -2%
Barclays
Oct 6, 22
■ Equal-Weight neutral · not a buy · 🎯$8
Price at call : $7.06 — gap to target +13%
Today : $17.39 — gap to target -54%
🎯 on SHC : 36% (14 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 6, 23
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)